TuHURA Biosciences, Inc. (HURA) vs Pyxis Oncology, Inc. (PYXS)
A side-by-side comparison of TuHURA Biosciences, Inc. and Pyxis Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HURA
TuHURA Biosciences, Inc.
$1.95HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PYXS
Pyxis Oncology, Inc.
$2.02HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — HURA vs PYXS
growth of $100 · dividends reinvested · last 5yHURA -95.3% (-45.8%/yr)PYXS -83.0% (-29.9%/yr)PYXS compounded faster over this window
HURA PYXS
HURA vs PYXS: by the numbers
- •PYXS is the larger company ($128M vs $124M market cap).
- •Both run net losses; HURA's is the smaller (0.00% vs -803.83% net margin).
Metrics side by side
Valuation
| Metric | HURA | PYXS |
|---|---|---|
| P/S ratio | N/A | 11.59 |
| P/B ratio | 6.81 | 11.19 |
Profitability
| Metric | HURA | PYXS |
|---|---|---|
| Gross margin | 0.00% | 82.77% |
| Operating margin | 0.00% | -609.18% |
| Net margin | 0.00% | -803.83% |
| ROE | -165.57% | -775.59% |
| ROIC | -137.40% | -314.66% |
Growth (annualized)
| Metric | HURA | PYXS |
|---|---|---|
| Total return CAGR (5Y) | -45.49% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.